South Korea · Delayed Price · Currency is KRW XIIlab Co.,Ltd Statistics
Total Valuation
XIIlab Co.,Ltd has a market cap or net worth of KRW 86.22 billion. The enterprise value is 64.09 billion.
| Market Cap | 86.22B |
| Enterprise Value | 64.09B |
Important Dates
The last earnings date was Thursday, May 28, 2026.
| Earnings Date | May 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
XIIlab Co.,Ltd has 9.38 million shares outstanding. The number of shares has increased by 34.01% in one year.
| Current Share Class | 9.38M |
| Shares Outstanding | 9.38M |
| Shares Change (YoY) | +34.01% |
| Shares Change (QoQ) | -0.24% |
| Owned by Insiders (%) | 31.52% |
| Owned by Institutions (%) | n/a |
| Float | 6.42M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.13 |
| PB Ratio | 3.68 |
| P/TBV Ratio | 3.69 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.05 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 17.27, with a Debt / Equity ratio of 0.01.
| Current Ratio | 17.27 |
| Quick Ratio | 16.56 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.09 |
| Interest Coverage | -98.19 |
Financial Efficiency
Return on equity (ROE) is -25.13% and return on invested capital (ROIC) is -15.26%.
| Return on Equity (ROE) | -25.13% |
| Return on Assets (ROA) | -13.79% |
| Return on Invested Capital (ROIC) | -15.26% |
| Return on Capital Employed (ROCE) | -16.68% |
| Weighted Average Cost of Capital (WACC) | 11.73% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.57 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, XIIlab Co.,Ltd has paid 1.14 million in taxes.
| Income Tax | 1.14M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +1.16% in the last 52 weeks. The beta is 1.36, so XIIlab Co.,Ltd's price volatility has been higher than the market average.
| Beta (5Y) | 1.36 |
| 52-Week Price Change | +1.16% |
| 50-Day Moving Average | 7,559.60 |
| 200-Day Moving Average | 5,449.38 |
| Relative Strength Index (RSI) | 51.62 |
| Average Volume (20 Days) | 625,880 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, XIIlab Co.,Ltd had revenue of KRW 10.60 billion and -4.04 billion in losses. Loss per share was -494.93.
| Revenue | 10.60B |
| Gross Profit | 2.38B |
| Operating Income | -4.08B |
| Pretax Income | -4.04B |
| Net Income | -4.04B |
| EBITDA | -3.16B |
| EBIT | -4.08B |
| Loss Per Share | -494.93 |
Balance Sheet
The company has 22.46 billion in cash and 326.82 million in debt, with a net cash position of 22.14 billion or 2,359.48 per share.
| Cash & Cash Equivalents | 22.46B |
| Total Debt | 326.82M |
| Net Cash | 22.14B |
| Net Cash Per Share | 2,359.48 |
| Equity (Book Value) | 23.41B |
| Book Value Per Share | 2,495.16 |
| Working Capital | 22.79B |
Cash Flow
In the last 12 months, operating cash flow was -3.06 billion and capital expenditures -778.61 million, giving a free cash flow of -3.84 billion.
| Operating Cash Flow | -3.06B |
| Capital Expenditures | -778.61M |
| Depreciation & Amortization | 922.54M |
| Net Borrowing | -661.91M |
| Free Cash Flow | -3.84B |
| FCF Per Share | -409.42 |
Margins
Gross margin is 22.47%, with operating and profit margins of -38.52% and -38.12%.
| Gross Margin | 22.47% |
| Operating Margin | -38.52% |
| Pretax Margin | -38.11% |
| Profit Margin | -38.12% |
| EBITDA Margin | -29.81% |
| EBIT Margin | -38.52% |
| FCF Margin | n/a |
Dividends & Yields
XIIlab Co.,Ltd does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -34.01% |
| Shareholder Yield | -34.01% |
| Earnings Yield | -4.69% |
| FCF Yield | -4.46% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 15, 2021. It was a forward split with a ratio of 2.
| Last Split Date | Sep 15, 2021 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
XIIlab Co.,Ltd has an Altman Z-Score of 11.72 and a Piotroski F-Score of 4.
| Altman Z-Score | 11.72 |
| Piotroski F-Score | 4 |